Advertisement Sidebar
Recent Posts
- Edetek’s CONFORM Platform: Streamlining Clinical Data Management in Oncology Trials
- NATERA GALAXY Study Links ctDNA Status to Survival & Treatment Response ESMO 2024
- FDA approves KEYTRUDA® / Pembrolizumab with Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma SLIDES
- SLIDES: FDA Approves Kisqali / Ribociclib for Early High-Risk Breast Cancer
- VIDEO: iTeos and GSK’s TIGIT Combination Therapy Shows Significant Promise at ESMO 2024
Oncology Conference Videos
Oncology News
In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…
By: Hope Rugo, MD Date: 12/9/2023 At the SABCS 2023 conference, medical oncologist Hope Rugo…
By. Kellogg Parsons, MD Date: 12/07/2023 Kellogg Parsons, MD, a medical doctor and Vice President of…
At ASH 2023, Katherine Broome, MD, a medical doctor and medical oncologist at the Georgetown…
By: Carol Fabian, MD Date. 12/07/2023 In an interview, Carol Fabian, MD, an expert in breast…
By. Ruth O’Regan MD Date: 12/07/2023In an interview, Ruth O’Regan MD addresses questions related to the…
By: Melinda Telli, MD, Date: 12/9/2023 At the SABCS 2023 conference, we had the privilege…
At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…
In this ASH 2023 interview, Dr. Jos Melenhorst discusses a collaborative study on single-cell multi-omics…
By: Hatem Azim, MD Date. 12/08/2023At SABCS 2023, a discussion on fertility preservation and assisted reproductive…
At ASH 2023, there is a discussion with Dr. Davide Matino, Assistant Professor of Medicine at…
Zahra Pakbaz, MD, shed light on a range of critical findings from the American Society…